CD70 and Th17 are involved in human contact sensitivity

Journal of Drugs in Dermatology

Volumn 10, Issue 10, 2011, Pages 1192-1194

  Lee, David S ^a   Gulati, Nicholas ^b   Martiniuk, Frank ^c   Levis, William R ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD27 ANTIGEN; CD70 ANTIGEN; CD70 MONOCLONAL ANTIBODY; CYTOKINE ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RETINOID ORPHAN RECEPTOR GAMMA T; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTHRITIS; ARTICLE; CD8+ T LYMPHOCYTE; COLITIS; CONTACT SENSITIVITY; DRUG RESEARCH; KIDNEY CARCINOMA; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; NONHUMAN; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SKIN ALLERGY; TH17 CELL; UPREGULATION;

ANIMALS; ANTIGENS, CD70; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, CONTACT; GENE EXPRESSION REGULATION; HUMANS; KILLER CELLS, NATURAL; MICE; NATURAL KILLER T-CELLS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH17 CELLS; UP-REGULATION;

EID: 80054723853     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kawamura T, Ogawa Y, Shimozato O, et al. CD70 is selectively expressed on Th1 but not on Th2 cells and is required for Th1-type immune responses. J Invest Dermatol. 2011;131(6):1252-1261. Epub April 14, 2011.
2. Martiniuk F, Lee DS, Gaspari A, et al. Expression of CD70 and the TH17 transcription factor RORgammaT in human contact dermatitis. J Drugs Dermatol. 2008;7(10):956-960.
3. Zhao Y, Balato A, Fishelevich R, et al. Th17/Tc17 infiltration and associated cytokine gene expression in elicitation phase of allergic contact dermatitis. Br J Dermatol. 2009;161(6):1301-1306. Epub July 7, 2009.
4. Jabbari A, Johnson-Huang LM, Krueger JG. Role of the immune system and immunological circuits in psoriasis. G Ital Dermatol Venereol. 2011;146(1):17-30.
5. Manocha M, Rietdijk S, Laouar A, et al. Blocking CD27-CD70 costimulatory pathway suppresses experimental colitis. J Immunol. 2009;183(1):270-276. Epub Jun 12, 2009.
6. Oflazoglu E, Boursalian TE, Zeng W, et al. Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis. J Immunol. 2009;183(6):3770-3777. Epub August 26, 2009.
7. Martiniuk F, Damian DL, Thompson JF, et al. TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone. J Drugs Dermatol. 2010;9(11):1368-1372.
8. Keller AM, Groothuis TA, Veraar EA, et al. Costimulatory ligand CD70 is delivered to the immunological synapse by shared intracellular trafficking with MHC class II molecules. Proc Natl Acad Sci USA. 2007;104(14):5989-5994. Epub March 26, 2007.
9. Huang J, Kerstann KW, Ahmadzadeh M, et al. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: Importance for the therapeutic effectiveness of cell transfer immunotherapy. J Immunol. 2006;176(12):7726-7735. (Pubitemid 43849073)
10. Byrne KT, Côté AL, Zhang P, et al. Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma. J Clin Invest. 2011;121(5):1797-1809. Epub April 11, 2011.
11. Muranski P, Boni A, Antony PA, et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood. 2008;112(2):362-373. Epub March 19, 2008.
12. Wang CQ, Cruz-Inigo AE, Fuentes-Duculan J, et al. Th17 cells and activated dendritic cells are increased in vitiligo lesions. PLoS One. 2011;6(4):e18907.
13. Gober MD, Fishelevich R, Zhao Y, et al. Human natural killer T cells infiltrate into the skin at elicitation sites of allergic contact dermatitis. J Invest Dermatol. 2008;128(6):1460-1469. Epub Dec 13, 2007.
14. Taraban VY, Martin S, Attfield KE, et al. Invariant NKT cells promote CD8+ cytotoxic T cell responses by inducing CD70 expression on dendritic cells. J Immunol. 2008;180(7):4615-4620.
15. Vossen MT, Matmati M, Hertoghs KM, et al. CD27 defines phenotypically and functionally different human NK cell subsets. J Immunol. 2008;180(6):3739-3745.
16. Ambrosino E, Terabe M, Halder RC, et al. Cross-regulation between type I and type II NKT cells in regulating tumor immunity: A new immunoregulatory axis. J Immunol. 2007;179(8):5126-5136.
17. Shaw S, Levis WR, Dattner AM, et al. Specificity of human cytotoxic responses to chemically modified autologous cells. Transplant Proc. 1978;10(4):937-941. (Pubitemid 9113867)